Du, et al. showed that release of VEGF and HIF-1α by tumor cells, in combination with stromal cell-derived factor 1 (SDF-1) and C-X-C chemokine receptor type 4 (CXCR-4) receptor activation, spurred mobilization of BMDCs to the invasive tumor front. Here, CXCR4 is linked to neoplasm.